DOCSLIB.ORG

Locus IL-10 Enhancer in the Through a STAT5-Responsive Intronic Regulatory T Cells Is Enhanced by IL-2 the Production of IL-10 B

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Locus IL-10 Enhancer in the Through a STAT5-Responsive Intronic Regulatory T Cells Is Enhanced by IL-2 the Production of IL-10 B The Production of IL-10 by Human Regulatory T Cells Is Enhanced by IL-2 through a STAT5-Responsive Intronic Enhancer in the IL-10 Locus This information is current as of September 26, 2021. Kazue Tsuji-Takayama, Motoyuki Suzuki, Mayuko Yamamoto, Akira Harashima, Ayumi Okochi, Takeshi Otani, Toshiya Inoue, Akira Sugimoto, Terumasa Toraya, Makoto Takeuchi, Fumiyuki Yamasaki, Shuji Nakamura and Masayoshi Kibata Downloaded from J Immunol 2008; 181:3897-3905; ; doi: 10.4049/jimmunol.181.6.3897 http://www.jimmunol.org/content/181/6/3897 http://www.jimmunol.org/ References This article cites 51 articles, 24 of which you can access for free at: http://www.jimmunol.org/content/181/6/3897.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 26, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2008 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology The Production of IL-10 by Human Regulatory T Cells Is Enhanced by IL-2 through a STAT5-Responsive Intronic Enhancer in the IL-10 Locus Kazue Tsuji-Takayama,* Motoyuki Suzuki,* Mayuko Yamamoto,* Akira Harashima,* Ayumi Okochi,* Takeshi Otani,* Toshiya Inoue,* Akira Sugimoto,* Terumasa Toraya,* Makoto Takeuchi,* Fumiyuki Yamasaki,† Shuji Nakamura,1* and Masayoshi Kibata* STAT5 molecules are key components of the IL-2 signaling pathway, the deficiency of which often results in autoimmune pa- thology due to a reduced number of CD4؉CD25؉ naturally occurring regulatory T (Treg) cells. One of the consequences of the IL-2-STAT5 signaling axis is up-regulation of FOXP3, a master control gene for naturally occurring Treg cells. However, the roles of STAT5 in other Treg subsets have not yet been elucidated. We recently demonstrated that IL-2 enhanced IL-10 production Downloaded from through STAT5 activation. This occurred in two types of human Treg cells: a novel type of umbilical cord blood-derived Treg cell, termed HOZOT, and Tr1-like Treg cells, IL-10-Treg. In this study, we examined the regulatory mechanisms of IL-10 production in these Treg cells, focusing specifically on the roles of STAT5. By performing bioinformatic analysis on the IL-10 locus, we identified one STAT-responsive element within intron 4, designated I-SRE-4, as an interspecies-conserved sequence. We found that I-SRE-4 acted as an enhancer element, and clustered CpGs around the I-SRE-4 were hypomethylated in IL-10-producing Treg cells, but not in other T cells. A gel-shift analysis using a nuclear extract from IL-2-stimulated HOZOT confirmed that CpG DNA http://www.jimmunol.org/ methylation around I-SRE-4 reduced STAT5 binding to the element. Chromatin immunoprecipitation analysis revealed the in situ binding of IL-2-activated STAT5 to I-SRE-4. Thus, we provide molecular evidence for the involvement of an IL-2-STAT5 signaling axis in the expression of IL-10 by human Treg cells, an axis that is regulated by the intronic enhancer, I-SRE-4, and epigenetic modification of this element. The Journal of Immunology, 2008, 181: 3897–3905. he STAT molecules play key roles in intracellular signal revealed the contribution of STAT5 molecules to nTreg develop- transduction after cellular stimulation by cytokines, ment because a subset of these mice exhibited autoimmune pa- T growth factors, and hormones. Among seven mammalian thology very similar to IL-2 or IL-2R knockout mice (7). A human by guest on September 26, 2021 family members, two highly related STAT5 gene products, patient with a STAT5b mutation displayed immune dysregulation STAT5a and STAT5b, have been of particular interest because associated with decreased numbers and impaired suppressive abil- their activation can be induced by a wide spectrum of cytokines. ity of CD4ϩCD25high cells, indicating both developmental and Recently, especially in regulatory T (Treg)2 biology, STAT5 pro- functional defects of nTreg cells (8). An essential role of STAT5 teins have been recognized as particularly important due to their molecules in the IL-2/IL-2R signaling pathway was confirmed by essential downstream roles in the IL-2/IL-2R signaling pathway experiments using mice with an IL-2R␤ mutation, which exclu- (1–4). Naturally occurring Treg (nTreg) cells are generated and sively activates STAT5 (4). Therefore, the IL-2-STAT5 signaling maintained in an IL-2-dependent manner. This was demonstrated axis contributes to some of the essential properties of nTreg cells. in studies of mice deficient for IL-2, IL-2R␣, and IL-2R␤, in which Furthermore, one result of the IL-2-STAT5 signaling axis is the autoimmune diseases developed due to lower numbers of nTregs enhancement of nTreg-specific gene expression, the transcription (5, 6). Also, studies of STAT5a and STAT5b double-knockout mice factor FOXP3 (4). It has been shown that STAT5 molecules di- rectly control FOXP3 gene expression, and STAT consensus se- quences were identified within promoter or intron regions (4, 9). *Cell Biology Institute, Research Center, Hayashibara Biochemical Laboratories, Fu- jisaki, Okayama, Japan; and †Kurashiki Medical Center, Bakuro-cho, Kurashiki, Although roles of IL-2/IL-2R signaling were firmly established in Japan nTreg cells, its roles in other types of Treg cells are poorly Received for publication April 15, 2008. Accepted for publication July 10, 2008. understood. The costs of publication of this article were defrayed in part by the payment of page IL-10 is an inhibitory cytokine mediating suppression by regu- charges. This article must therefore be hereby marked advertisement in accordance latory or suppressor T cells (10). Despite its essential roles in im- with 18 U.S.C. Section 1734 solely to indicate this fact. mune responses, the mechanisms regulating IL-10 production are 1 Address correspondence and reprint requests to Dr. Shuji Nakamura, Cell Biology not well understood. We previously reported that IL-2 was effec- Institute, Research Center, Hayashibara Biochemical Laboratories, 675-1 Fujisaki, Okayama 702-8006, Japan. E-mail address: [email protected] tive for enhancement of IL-10 production in certain types of Treg 2 Abbreviations used in this paper: Treg, regulatory T; ARRE, Ag receptor-responsive cells (11). Such cells are categorized as IL-10-producing Treg elements; ChIP, chromatin immunoprecipitation; CNS, conserved noncoding se- cells, including Tr1-like cells, IL-10-Treg, and a newly character- quences; conT, conventional T; DC, dendritic cell; HS, hypersensitivity; I-SRE-4, ized Treg cell line (designated HOZOT) with a phenotype of STAT-responsive element within intron 4; nTreg, naturally occurring regulatory T; ϩ ϩ P-SRE, STAT-responsive element within proximal region; pAb, polyclonal Ab; CD4 CD8 . In that study, we analyzed the mechanisms of high rVISTA, Regulatory Visualization Tools for Alignment; SRE, STAT-responsive el- IL-10 production by these Treg cells in comparison with other T ement; TSS, transcription start site; UCB, umbilical cord blood. cells, especially Th2 cells, which are typical high producers of Copyright © 2008 by The American Association of Immunologists, Inc. 0022-1767/08/$2.00 IL-10 among non-Treg cells. For Th2 cells, both transcriptional www.jimmunol.org 3898 Treg PRODUCED IL-10 THROUGH AN INTRONIC ENHANCER and epigenetic mechanisms have been reported in the regulation of Systems) and CD28 mAb (37407.111; R&D Systems) (CD3/CD28) in the IL-10 production. At the transcriptional level, transcriptional acti- presence of 10 ng/ml IL-2. The IL-10-producing Treg (IL-10-Treg) cell line was also obtained from vators, such as c-jun, jun B (12), and NF-AT (13), have been ϩ Ϫ CD4 CD25 mononuclear cells, as previously described (27). The cells documented as essential molecules for IL-10 production. At an were cultured on immature DC derived from UCB in the presence of 1 nM epigenetic level, a Th2-specific transcription factor, GATA-3, has vitamin D3 (Sigma-Aldrich) and 50 nM dexamethasone (Sigma-Aldrich). been described as a chromatin remodeling molecule. GATA3 can The cells were expanded for another 2 wk in the presence of vitamin D3/dexamethasone and IL-2. bind to DNase I hypersensitivity (HS) sites residing on both the ϩ Ϫ Ј The Th2 cell line was obtained from CD4 CD25 mononuclear cells, 5 -proximal region and intron 4, and then induce remodeling of as described previously (28). The cells were cultured with plate-bound chromatin structure by increasing histone acetylation (14). In this CD3/CD28 in the presence of 10 ng/ml human rIL-4 (PeproTech) and 4 situation, GATA-3 acts as a stabilizing factor, and not a transcrip- ␮g/ml anti-human IFN-␥ mAb (Hayashibara Biochemical Laboratories) tional activator, keeping an open chromatin configuration for the for 48 h. Then, the cells were expanded by addition of 10 ng/ml IL-2. After ␥ IL-10 gene. Our previous study indicated that, in contrast to Th2 6 days, the production of IL-10, IFN- , and IL-4 was assessed in the su- pernatants from the CD3/CD28-treated cells. cells, GATA-3 plays a less important role in IL-10-producing Treg Naive T cells were prepared as CD4ϩCD25Ϫ mononuclear cells. The cells (IL-10-Treg and HOZOT) because GATA-3 expression in percentage of CD45RAϩ cells was Ͼ90%.
Load more

Recommended publications
  • An Immunoevasive Strategy Through Clinically-Relevant Pan-Cancer Genomic and Transcriptomic Alterations of JAK-STAT Signaling Components
    bioRxiv preprint doi: https://doi.org/10.1101/576645; this version posted March 14, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. An immunoevasive strategy through clinically-relevant pan-cancer genomic and transcriptomic alterations of JAK-STAT signaling components Wai Hoong Chang1 and Alvina G. Lai1, 1Nuffield Department of Medicine, University of Oxford, Old Road Campus, Oxford, OX3 7FZ, United Kingdom Since its discovery almost three decades ago, the Janus ki- Although cytokines are responsible for inflammation in nase (JAK)-signal transducer and activator of transcription cancer, spontaneous eradication of tumors by endoge- (STAT) pathway has paved the road for understanding inflam- nous immune processes rarely occurs. Moreover, the matory and immunity processes related to a wide range of hu- dynamic interaction between tumor cells and host immu- man pathologies including cancer. Several studies have demon- nity shields tumors from immunological ablation, which strated the importance of JAK-STAT pathway components in overall limits the efficacy of immunotherapy in the clinic. regulating tumor initiation and metastatic progression, yet, the extent of how genetic alterations influence patient outcome is far from being understood. Focusing on 133 genes involved in Cytokines can be pro- or anti-inflammatory and are inter- JAK-STAT signaling, we found that copy number alterations dependent on each other’s function to maintain immune underpin transcriptional dysregulation that differs within and homeostasis(3).
    [Show full text]
  • The Effect of STAT5 on Inflammation-Related Gene Expression in Diabetic Mouse
    The Effect of STAT5 on Inflammation-Related Gene Expression in Diabetic Mouse Kidneys A thesis presented to the faculty of the College of Arts and Sciences of Ohio University In partial fulfillment of the requirements for the degree Master of Science Samantha J. Shaw May 2014 © 2014 Samantha J. Shaw. All Rights Reserved. 2 This thesis titled The Effect of STAT5 on Inflammation-Related Gene Expression in Diabetic Mouse Kidneys by SAMANTHA J. SHAW has been approved for the Department of Biological Sciences and the College of Arts and Sciences by Karen T. Coschigano Associate Professor of Biomedical Sciences Robert Frank Dean, College of Arts and Sciences 3 ABSTRACT SHAW, SAMANTHA J., M.S., May 2014, Biological Sciences The Effect of STAT5 on Inflammation-Related Gene Expression in Diabetic Mouse Kidneys Director of Thesis: Karen T. Coschigano Diabetic nephropathy (DN) is the leading cause of end-stage renal disease and renal failure in humans. The molecular pathways that lead to DN are not well known. This research investigates possible roles of several signal transducers and activators of transcription (STAT) proteins in this disease using a STAT5A/B knockout (SKO) mouse model. Based on previous observations of increased inflammation-related gene expression in the kidneys of diabetic SKO mice, the hypothesis of the current project was that the combination of the loss of STAT5 repression and increase of STAT3 activity escalates inflammation-related gene expression in the kidneys of diabetic SKO mice. In support of this hypothesis, an increase of IRF-1 RNA expression, reflective of the loss of STAT5 repression, was observed in the kidneys of diabetic SKO mice.
    [Show full text]
  • Myeloid-Derived Suppressor Cell Development Is Regulated by a STAT/IRF-8 Axis
    Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis Jeremy D. Waight, … , Kebin Liu, Scott I. Abrams J Clin Invest. 2013;123(10):4464-4478. https://doi.org/10.1172/JCI68189. Research Article Immunology Myeloid-derived suppressor cells (MDSCs) comprise immature myeloid populations produced in diverse pathologies, including neoplasia. Because MDSCs can impair antitumor immunity, these cells have emerged as a significant barrier to cancer therapy. Although much research has focused on how MDSCs promote tumor progression, it remains unclear how MDSCs develop and why the MDSC response is heavily granulocytic. Given that MDSCs are a manifestation of aberrant myelopoiesis, we hypothesized that MDSCs arise from perturbations in the regulation of interferon regulatory factor–8 (IRF-8), an integral transcriptional component of myeloid differentiation and lineage commitment. Overall, we demonstrated that (a) Irf8-deficient mice generated myeloid populations highly homologous to tumor-induced MDSCs with respect to phenotype, function, and gene expression profiles; (b) IRF-8 overexpression in mice attenuated MDSC accumulation and enhanced immunotherapeutic efficacy; (c) the MDSC-inducing factors G-CSF and GM-CSF facilitated IRF-8 downregulation via STAT3- and STAT5-dependent pathways; and (d) IRF-8 levels in MDSCs of breast cancer patients declined with increasing MDSC frequency, implicating IRF-8 as a negative regulator in human MDSC biology. Together, our results reveal a previously unrecognized role for IRF-8 expression in MDSC subset development, which may provide new avenues to target MDSCs in neoplasia. Find the latest version: https://jci.me/68189/pdf Research article Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis Jeremy D.
    [Show full text]
  • Modulation of STAT Signaling by STAT-Interacting Proteins
    Oncogene (2000) 19, 2638 ± 2644 ã 2000 Macmillan Publishers Ltd All rights reserved 0950 ± 9232/00 $15.00 www.nature.com/onc Modulation of STAT signaling by STAT-interacting proteins K Shuai*,1 1Departments of Medicine and Biological Chemistry, University of California, Los Angeles, California, CA 90095, USA STATs (signal transducer and activator of transcription) play important roles in numerous cellular processes Interaction with non-STAT transcription factors including immune responses, cell growth and dierentia- tion, cell survival and apoptosis, and oncogenesis. In Studies on the promoters of a number of IFN-a- contrast to many other cellular signaling cascades, the induced genes identi®ed a conserved DNA sequence STAT pathway is direct: STATs bind to receptors at the named ISRE (interferon-a stimulated response element) cell surface and translocate into the nucleus where they that mediates IFN-a response (Darnell, 1997; Darnell function as transcription factors to trigger gene activa- et al., 1994). Stat1 and Stat2, the ®rst known members tion. However, STATs do not act alone. A number of of the STAT family, were identi®ed in the transcription proteins are found to be associated with STATs. These complex ISGF-3 (interferon-stimulated gene factor 3) STAT-interacting proteins function to modulate STAT that binds to ISRE (Fu et al., 1990, 1992; Schindler et signaling at various steps and mediate the crosstalk of al., 1992). ISGF-3 consists of a Stat1:Stat2 heterodimer STATs with other cellular signaling pathways. This and a non-STAT protein named p48, a member of the article reviews the roles of STAT-interacting proteins in IRF (interferon regulated factor) family (Levy, 1997).
    [Show full text]
  • Batf3 and Id2 Have a Synergistic Effect on Irf8-Directed Classical Cd8α+ Dendritic Cell Development
    Batf3 and Id2 Have a Synergistic Effect on Irf8-Directed Classical CD8α+ Dendritic Cell Development This information is current as Hemant Jaiswal, Monika Kaushik, Rachid Sougrat, Monica of October 3, 2021. Gupta, Anup Dey, Rohit Verma, Keiko Ozato and Prafullakumar Tailor J Immunol 2013; 191:5993-6001; Prepublished online 13 November 2013; doi: 10.4049/jimmunol.1203541 http://www.jimmunol.org/content/191/12/5993 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2013/11/13/jimmunol.120354 Material 1.DC1 http://www.jimmunol.org/ References This article cites 57 articles, 38 of which you can access for free at: http://www.jimmunol.org/content/191/12/5993.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on October 3, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Batf3 and Id2 Have a Synergistic Effect on Irf8-Directed Classical CD8a+ Dendritic Cell Development Hemant Jaiswal,* Monika Kaushik,* Rachid Sougrat,† Monica Gupta,‡ Anup Dey,‡ Rohit Verma,* Keiko Ozato,‡ and Prafullakumar Tailor* Dendritic cells (DCs) are heterogeneous cell populations represented by different subtypes, each varying in terms of gene expression patterns and specific functions.
    [Show full text]
  • Mutation of Thyroid Hormone Receptor-&Beta
    Oncogene (2011) 30, 3381–3390 & 2011 Macmillan Publishers Limited All rights reserved 0950-9232/11 www.nature.com/onc ORIGINAL ARTICLE Mutation of thyroid hormone receptor-b in mice predisposes to the development of mammary tumors CJ Guigon1, DW Kim1, MC Willingham2 and S-y Cheng1 1Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA and 2Department of Pathology, Wake Forest University, Winston-Salem, NC, USA Correlative data suggest that thyroid hormone receptor-b Introduction (TRb) mutations could increase the risk of mammary tumor development, but unequivocal evidence is still Thyroid hormone receptors (TRs) belong to the lacking. To explore the role of TRb mutants in vivo in superfamily of nuclear receptors that are ligand- breast tumor development and progression, we took dependent transcription factors. Two TR genes, THRA advantage of a knock-in mouse model harboring a and THRB, located on chromosomes 17 and 3, respec- mutation in the Thrb gene encoding TRb (ThrbPV mouse). tively, encode four thyroid hormone (T3)-binding Although in adult nulliparous females, a single ThrbPV receptors: TRa1, TRb1, TRb2 and TRb3. They bind allele did not contribute to mammary gland abnormalities, T3 that has critical roles in differentiation, growth and the presence of two ThrbPV alleles led to mammary metabolism (Yen, 2001). hyperplasia in B36% ThrbPV/PV mice. The ThrbPV Several findings support the notion that mutations of mutation further markedly augmented the risk of TRs can be associated with cancer. Early evidence mammary hyperplasia in a mouse model with high suggested that mutated TRs could be involved in susceptibility to mammary tumors (Pten þ /À mouse), as carcinogenesis came from the discovery that v-erbA, a demonstrated by the occurrence of mammary hyperplasia highly mutated chicken THRA1 that has lost the ability in B60% of ThrbPV/ þ Pten þ /À and B77% of ThrbPV/PV to activate gene transcription, leads to neoplastic trans- Pten þ /À mice versus B33% of Thrb þ / þ Pten þ /À mice.
    [Show full text]
  • Interpretation of Cytokine Signaling Through the Transcription Factors STAT5A and STAT5B
    Downloaded from genesdev.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B Lothar Hennighausen1 and Gertraud W. Robinson Laboratory of Genetics and Physiology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA Transcription factors from the family of Signal Trans- the “wrong” STATs and thus acquire inappropriate cues. ducers and Activators of Transcription (STAT) are acti- We propose that mice with mutations in various com- vated by numerous cytokines. Two members of this fam- ponents of the JAK–STAT signaling pathway are living ily, STAT5A and STAT5B (collectively called STAT5), laboratories, which will provide insight into the versa- have gained prominence in that they are activated by a tility of signaling hardware and the adaptability of the wide variety of cytokines such as interleukins, erythro- software. poietin, growth hormone, and prolactin. Furthermore, constitutive STAT5 activation is observed in the major- ity of leukemias and many solid tumors. Inactivation Historical perspective studies in mice as well as human mutations have pro- In 1994, Bernd Groner and colleagues (Wakao et al. vided insight into many of STAT5’s functions. Disrup- 1994), then at the Friedrich Miescher Institute in Basel, tion of cytokine signaling through STAT5 results in a cloned a cDNA from lactating ovine mammary tissue variety of cell-specific effects, ranging from a defective that encoded a transcription factor promoting prolactin- immune system and impaired erythropoiesis, the com- induced transcription of milk protein genes in mammary plete absence of mammary development during preg- epithelium.
    [Show full text]
  • Mast Cell STAT6 IL-4 Induces the Proteolytic Processing Of
    IL-4 Induces the Proteolytic Processing of Mast Cell STAT6 Melanie A. Sherman, Doris R. Powell and Melissa A. Brown This information is current as J Immunol 2002; 169:3811-3818; ; of September 28, 2021. doi: 10.4049/jimmunol.169.7.3811 http://www.jimmunol.org/content/169/7/3811 Downloaded from References This article cites 74 articles, 47 of which you can access for free at: http://www.jimmunol.org/content/169/7/3811.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 28, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2002 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology IL-4 Induces the Proteolytic Processing of Mast Cell STAT61 Melanie A. Sherman, Doris R. Powell, and Melissa A. Brown2 IL-4 is a potent, pleiotropic cytokine that, in general, directs cellular activation, differentiation, and rescue from apoptosis. However, in mast cells, IL-4 induces the down-regulation of activation receptors and promotes cell death.
    [Show full text]
  • STAT3 Impairs STAT5 Activation in the Development of IL-9–Secreting T Cells
    STAT3 Impairs STAT5 Activation in the Development of IL-9−Secreting T Cells Matthew R. Olson, Felipe Fortino Verdan, Matthew M. Hufford, Alexander L. Dent and Mark H. Kaplan This information is current as of September 29, 2021. J Immunol published online 14 March 2016 http://www.jimmunol.org/content/early/2016/03/11/jimmun ol.1501801 Downloaded from Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision http://www.jimmunol.org/ • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription by guest on September 29, 2021 Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published March 14, 2016, doi:10.4049/jimmunol.1501801 The Journal of Immunology STAT3 Impairs STAT5 Activation in the Development of IL-9–Secreting T Cells Matthew R. Olson,* Felipe Fortino Verdan,*,† Matthew M. Hufford,* Alexander L. Dent,‡ and Mark H. Kaplan*,‡ Th cell subsets develop in response to multiple activating signals, including the cytokine environment. IL-9–secreting T cells develop in response to the combination of IL-4 and TGF-b, although they clearly require other cytokine signals, leading to the activation of transcription factors including STAT5.
    [Show full text]
  • Evidence for a Protective Role of the STAT5 Transcription Factor Against Oxidative Stress in Human Leukemic Pre-B Cells
    Leukemia (2012) 26, 2390–2397 & 2012 Macmillan Publishers Limited All rights reserved 0887-6924/12 www.nature.com/leu ORIGINAL ARTICLE Evidence for a protective role of the STAT5 transcription factor against oxidative stress in human leukemic pre-B cells E Cholez1,5, V Debuysscher1,5, J Bourgeais6, C Boudot1, J Leprince2, F Tron3, B Brassart4, A Regnier1, E Bissac1, E Pecnard6, F Gouilleux6, K Lassoued1,6 and V Gouilleux-Gruart1,5,6 STAT5 transcription factors are involved in normal B lymphocyte development and in leukemogenesis. We show that the inhibition of STAT5A expression or activity in the NALM6, 697 and Reh leukemic pre-B cell lines, results in a higher spontaneous apoptosis and an increased FAS-induced cell death. However, the molecular mechanisms underlying the altered pre-B cell survival are unclear. We used a proteomic approach to identify proteins that are differentially regulated in cells expressing (NALM6D5A) or not a dominant negative form of STAT5A. Among the 14 proteins identified, six were involved in the control of the oxidative stress like glutathione (GSH) synthetase and DJ-1. Accordingly, we showed increased levels of reactive oxygen species (ROS) in NALM6D5A cells and suppression of the increased sensitivity to Fas-mediated apoptosis by the GSH tripeptide. Similar results were observed when NALM6 cells were treated with TAT-STAT5D5A fusion proteins or STAT5A shRNA. In addition, the 697 and Reh pre-B cells were found to share number of molecular changes observed in NALM6D5A cells including ROS generation, following inhibition of STAT5 expression or function. Our results point out to a hitherto undescribed link between STAT5 and oxidative stress and provide new insights into STAT5 functions and their roles in leukemogenesis.
    [Show full text]
  • The Role of Stat5a and Stat5b in Signaling by IL-2 Family Cytokines
    Oncogene (2000) 19, 2566 ± 2576 ã 2000 Macmillan Publishers Ltd All rights reserved 0950 ± 9232/00 $15.00 www.nature.com/onc The role of Stat5a and Stat5b in signaling by IL-2 family cytokines Jian-Xin Lin1 and Warren J Leonard*,1 1Laboratory of Molecular Immunology, National Heart, Lung and Blood Institute, National Institutes of Health, Bldg. 10/Rm. 7N252, 9000 Rockville Pike, Bethesda, Maryland MD 20892-1674, USA The activation of Stat5 proteins (Stat5a and Stat5b) is each of the IL-2 family cytokines contains at least one one of the earliest signaling events mediated by IL-2 other component, such as IL-2Rb, IL-4Ra, IL-7Ra and family cytokines, allowing the rapid delivery of signals IL-9Ra (Figure 1), that contributes both to binding and from the membrane to the nucleus. Among STAT family to transduction of speci®c signals (Leonard, 1999). proteins, Stat5a and Stat5b are the two most closely Because the receptors for IL-2 and IL-15 additionally related STAT proteins. Together with other transcription share IL-2Rb (Figure 1), IL-2 and IL-15 have the most factors and co-factors, they regulate the expression of overlapping biological activities of the ®ve cytokines. In the target genes in a cytokine-speci®c fashion. In contrast to IL-4, IL-7 and IL-9, the receptors for IL-2 addition to their activation by cytokines, activities of and IL-15 also have third components, IL-2Ra and IL- Stat5a and Stat5b, as well as other STAT proteins, are 15Ra (Lin and Leonard, 1997; Waldmann et al., 1998; negatively controlled by CIS/SOCS/SSI family proteins.
    [Show full text]
  • STAT5A Promotes Adipogenesis in Nonprecursor Cells and Associates with the Glucocorticoid Receptor During Adipocyte Differentiation Z
    STAT5A Promotes Adipogenesis in Nonprecursor Cells and Associates With the Glucocorticoid Receptor During Adipocyte Differentiation Z. Elizabeth Floyd and Jacqueline M. Stephens The differentiation of adipocytes is regulated by the (STATs) are a family of latent transcription factors that activity of a variety of transcription factors, including reside in the cytoplasm of resting cells. In response to peroxidase proliferator-activated receptor (PPAR)-␥ various stimuli, STATs become tyrosine phosphorylated and C/EBP␣. Our current study demonstrates that ec- and translocate to the nucleus, where they mediate tran- topic expression of STAT5A, such as that of PPAR-␥ and scriptional regulation. STATs can be rapidly activated to C/EBP␣, promotes adipogenesis in two nonprecursor regulate gene expression and represent a relatively unex- fibroblast cell lines. Using morphologic and biochemical plored paradigm in the transcriptional regulation of fat criteria, we have demonstrated that STAT5A and the combination of STAT5A and STAT5B are sufficient to cells (1). Numerous studies suggest that STATs are in- induce the expression of early and late adipogenic volved in regulation of tissue-specific genes. Transgenic markers in BALB/c and NIH-3T3 cells. Yet, the ectopic knockout experiments have revealed crucial roles for each expression of STAT5B alone does not induce the ex- known mammalian STAT (1), and cell-specific functions pression of adipocyte genes, but enhances the induction for STAT family members have been identified (2). How- of these genes in cells also expressing STAT5A. This ever, the specificity of STAT activation and function is not finding suggests that STAT5A and STAT5B do not func- completely understood. Specificity is determined, at least tion identically in adipocytes.
    [Show full text]